Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.009 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.009 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |